- Home
- PGY vs BHC Comparison
PGY vs BHC Comparison
Compare PGY & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGY
- BHC
- Stock Information
- Founded
- PGY 2016
- BHC N/A
- Country
- PGY United States
- BHC Canada
- Employees
- PGY N/A
- BHC N/A
- Industry
- PGY Finance: Consumer Services
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- PGY Finance
- BHC Health Care
- Exchange
- PGY Nasdaq
- BHC Nasdaq
- Market Cap
- PGY 2.6B
- BHC 2.2B
- IPO Year
- PGY N/A
- BHC N/A
- Fundamental
- Price
- PGY $29.38
- BHC $6.38
- Analyst Decision
- PGY Strong Buy
- BHC Hold
- Analyst Count
- PGY 7
- BHC 2
- Target Price
- PGY $39.43
- BHC $9.00
- AVG Volume (30 Days)
- PGY 5.5M
- BHC 1.4M
- Earning Date
- PGY 11-10-2025
- BHC 10-29-2025
- Dividend Yield
- PGY N/A
- BHC N/A
- EPS Growth
- PGY N/A
- BHC N/A
- EPS
- PGY N/A
- BHC 0.27
- Revenue
- PGY $1,153,015,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- PGY $27.78
- BHC $6.28
- Revenue Next Year
- PGY $16.22
- BHC $3.76
- P/E Ratio
- PGY N/A
- BHC $24.03
- Revenue Growth
- PGY 24.59
- BHC 7.13
- 52 Week Low
- PGY $8.20
- BHC $4.25
- 52 Week High
- PGY $44.99
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- PGY 44.62
- BHC 48.32
- Support Level
- PGY $26.95
- BHC $5.89
- Resistance Level
- PGY $30.34
- BHC $6.43
- Average True Range (ATR)
- PGY 2.29
- BHC 0.21
- MACD
- PGY 0.12
- BHC 0.03
- Stochastic Oscillator
- PGY 61.36
- BHC 60.63
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.